Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2023
Filing Date: August 14, 2023
Business Focus: The company focuses on the global adoption of cryoablation technology.
Key Financial Metrics
The provided text serves as a cover page and index for the Form 6-K filing. It references the Unaudited Interim Condensed Consolidated Financial Statements (Exhibit 99.1) and Management's Discussion and Analysis (Exhibit 99.2) but does not contain the specific numerical data within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative financial data or material changes versus the prior period. The referenced press release (Exhibit 99.3) indicates that the global adoption of the company's cryoablation technology is "gaining momentum," but specific quantitative changes are not detailed in the cover document.
Guidance, Outlook, and Risks
Management Commentary: The press release included in the filing highlights that the global adoption of Icecure Medical's cryoablation technology is gaining momentum.
Guidance and Risks: Specific forward-looking guidance, risk factors, contingencies, or unusual items are not detailed in the provided cover page text; these are contained within the attached exhibits (99.1, 99.2, and 99.3).
Investor Verification Checklist
- Review Exhibit 99.1 for specific revenue, net loss, and cash burn figures for the six months ended June 30, 2023.
- Examine Exhibit 99.2 for detailed analysis of liquidity, working capital, and debt obligations.
- Read Exhibit 99.3 (Press Release) for specific operational milestones and the context of "gaining momentum" in global adoption.
- Verify the company's cash runway and funding requirements in the full MD&A section.